Nanotherapeutics

34 articles about Nanotherapeutics

• Nanotherapeutics Announces Name Change To Ology Bioservices, Reflecting The Company’s Ongoing Transformation Into One Of The Top Contract Development And Manufacturing Organizations Of Vaccines And Biologics

  10/2/2017

• XOMA Earns $3 Million Milestone Payment From Its License Agreement With Nanotherapeutics

  9/11/2017

• Robert J. Hennessey Appointed Chairman Of The Board Of Nanotherapeutics

  6/22/2017

• Peter H. Khoury, Ph.D., MBA Appointed President And Chief Executive Officer Of Nanotherapeutics

  6/20/2017

• Battelle And Nanotherapeutics Form Alliance To Speed Up Process Of Industry Bringing Medical Countermeasures To Market

  4/5/2017

• Trethera And Nanotherapeutics Sign Exclusive Worldwide Agreement For Rights To Triapine In Hematological Malignancies

  1/5/2017

• Nanotherapeutics Appoints Prasad Raje, Ph.D. As President And Chief Executive Officer

  12/1/2016

• Nanotherapeutics Receives NIAID Contract As Part Of A Multiple Award Pool For Task Orders Valued At Up To $159.4 Million

  9/20/2016

• Former Bill & Melinda Gates Foundation And Baxter International Executive Peter H. Khoury, Ph.D. Joins Nanotherapeutics As Chief Commercial Officer

  8/3/2016

• Nanotherapeutics Closes Sale-Leaseback Financing With Senior Housing Properties Trust For The Company’s New Advanced Development And Manufacturing Facility In Alachua, FL

  5/6/2016

• Nanotherapeutics Grants Worldwide Rights To Amend Surgical For Nanofuse DBM

  1/6/2016

• Struggling XOMA Sells Biologics Manufacturing Facilities to Agenus, Divests Biodefense Program to Nanotherapeutics

  11/6/2015

• Takeda And Nanotherapeutics Announce Agreement To Expand Takeda's Commercialization And Technology Access Rights In Support Of Influenza And Other Vaccine Programs

  8/27/2015

• Nanotherapeutics Awarded Biomedical Advanced Research and Development Authority (BARDA) Fill-Finish Manufacturing Network Task Orders To Develop Two FDA Drug Shortage Products

  7/10/2015

• Nanotherapeutics Receives Expanded 510(K) Marketing Clearance From The FDA For Nanofuse DBM

  2/10/2015

• PharmAthene, Inc. And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs

  9/8/2014

• PharmAthene, Inc. And Nanotherapeutics Form Strategic Alliance To Advance Biodefense Programs

  9/8/2014

• Company Profile For Nanotherapeutics

  8/22/2014

• Nanotherapeutics Opens New Office In Frederick, MD

  8/19/2014

• Nanotherapeutics Secures $30 Million Loan

  6/3/2014